2024’s Top 7 VC Raises in Biotech BioSpace recaps 2024’s top venture capital rounds in biopharma, from Xaira Therapeutics’ blockbuster $1B raise to back-to-back series from obesity-focused Metsera that totaled more than $500M in a ... 01/14/2025 - 4:01 pm | View Link
Seattle biotech company raises $100 million Seattle-based Umoja Biopharma has raised a $100 million Series C round. With the funding, announced Tuesday, Umoja wants to advance its clinical pipeline. Its lead drug, UB-VV400 is aimed at cancer ... 01/14/2025 - 2:14 pm | View Link
Seattle immunotherapy startup Umoja Biopharma raises $100M Another Seattle-area health startup is raising a big new round of funding. Umoja Biopharma announced a $100 million Series C round that will help the Seattle-based company further develop its CAR ... 01/14/2025 - 3:55 am | View Link
Drug Company to Share Revenues With Indigenous People Who Donated Their Genes Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity and diabetes. 01/6/2025 - 11:04 pm | View Link
ZipBio, a new Seattle biotech startup aiming to compress proteins, raises $4M Seattle-based biotech startup ZipBio announced its official ... optimizing delivery and therapeutic effectiveness,” according to the company. ZipBio uses generative AI “to revolutionize ... 09/5/2024 - 5:25 am | View Link
A Mokena-based medical supplies executive who sits on the Lakeside Bank board is facing federal fraud charges for allegedly mislabeling and selling devices used in surgical procedures.
Anthony Iaderosa and his company, Synergy Surgical, are charged with removal of labeling on sutures, gauges and other products while the medical devices were held for sale, according to an indictment filed Monday in Chicago federal court.
Misbranding medical devices after shipment in interstate commerce is a felony under Food and Drug Administration regulations.
Iaderosa did not respond to several requests for comment.
A University of Illinois Urbana-Champaign graduate, Iaderosa founded the southwest suburban company, formerly known as eSutures, in 2000, carving out a medical supply chain niche as a wholesale liquidator of “brand name surgical supplies at discounted prices,” according to the firm’s website.
Synergy Surgical also buys surplus products for resale from hospitals and doctors, including open-boxed or loose individual items.
The current product inventory includes in-date and expired surgical equipment ranging from hypodermic needles and sutures to catheters, all listed by brand.
Walgreens plans to close five stores on the South and West sides of Chicago next month, drawing criticism from local leaders.
Four of the stores are on the South Side and one is on the West Side. The closings are part of the Deerfield-based retail pharmacy chain’s plan to shutter 1,200 stores over the next three years, as it struggles with operating losses and aims to cut costs.
“It is never an easy decision to close a store,” Walgreens spokesman Marty Maloney said in a statement.
CTA trains every five to 10 minutes all day and better Metra service at midday, nights and weekends. One app for fares and transfers across services. Buses that can bypass traffic.
This is the vision for the future of transit set to be outlined Wednesday by Regional Transportation Authority Chairman Kirk Dillard at a lunch for the city’s business and political elite.
Overseeing the efforts would be a stronger RTA that would coordinate fares, service and construction projects among city and suburban bus and train agencies, he said.